An Epigenetics Approach To Regulating IL-17 Signaling
This article was originally published in Start Up
Executive Summary
As a research strategy, epigenetics is largely thought of in the realm of cancer therapy. But Constellation Pharmaceuticals Inc. sees application to the development of immunology drugs through the regulation of IL-17 signaling, doing so farther upstream than the biologics that aim at either the molecule itself or its receptor.